TEVA PHARMACEUTICAL INDUSTRIES LIMITED Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period

TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 581.00 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-03.

Financial Statements › Shareholders' Equity

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-02-03

TEVA PHARMACEUTICAL INDUSTRIES LIMITED share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 581.00K shares, a 52.02% decline from fiscal 2024.
TEVA PHARMACEUTICAL INDUSTRIES LIMITED share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 1.21M shares, a 36.84% increase from fiscal 2023.
TEVA PHARMACEUTICAL INDUSTRIES LIMITED share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 885.00K shares, a 62.78% decline from fiscal 2022.
TEVA PHARMACEUTICAL INDUSTRIES LIMITED share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 2.38M shares, a 34.74% decline from fiscal 2021.

Period end	Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month
2025-12-31	581.00K shares 10-K · filed 2026-02-03
2024-12-31	1.21M shares 10-K · filed 2026-02-03
2023-12-31	885.00K shares 10-K · filed 2026-02-03
2022-12-31	2.38M shares 10-K · filed 2025-02-05
2021-12-31	3.64M shares 10-K · filed 2024-02-12
2020-12-31	3.61M shares 10-K · filed 2023-02-10
2019-12-31	8.32M shares 10-K · filed 2022-02-09
2018-12-31	7.04M shares 10-K · filed 2021-02-10
2017-12-31	4.95M shares 10-K · filed 2020-02-21
2016-12-31	1.38M shares 10-K · filed 2019-02-19